Page last updated: 2024-11-12
magainin a
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
magainin A: RN from CA Index Guide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 16132424 |
| MeSH ID | M0185663 |
Synonyms (4)
| Synonym |
|---|
| magainin i (xenopus laevis), 1-beta-alanine-8-l-alanine-10-l-lysine-13-l-alanine-18-l-alanine-22-l-asparagine-23-l-serinamide- |
| magainin a |
| 117665-47-1 |
| DTXSID20151861 |
Research Excerpts
Toxicity
| Excerpt | Reference | Relevance |
|---|---|---|
| " No adverse effect was observed on the erythrocytes." | ( Studies on safety aspects of contraceptive Magainin-A in rabbits. Aranha, C; Reddy, KV, 2000) | 0.31 |
Bioavailability
| Excerpt | Reference | Relevance |
|---|---|---|
| " The effect of this compound on the erythrocytes and its rate of absorption and clearance from systemic circulation was also studied." | ( Studies on safety aspects of contraceptive Magainin-A in rabbits. Aranha, C; Reddy, KV, 2000) | 0.31 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (11)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 11.74
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.74) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (9.09%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (90.91%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||